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Escherichia coli 
and Klebsiella 
pneumoniae  
Carbapenemase  
in Long-term Care 
Facility, Illinois, USA
To the Editor: Escherichia coli 
harboring Klebsiella pneumoniae car-
bapenemases (KPCs) are now rarely 
being reported. Worldwide, KPC-2 has 
been detected in Israel and the People’s 
Republic  of  China  (1,2).  Within  the 
United States, carbapenem-resistant E. 
coli carrying blaKPC has been isolated 
in New Jersey (3) and Cleveland, Ohio 
(4), and 7 carbapenem-resistant E. coli 
isolates were obtained from 3 differ-
ent hospitals in Brooklyn, New York 
(5). Urban et al. (6) recently reported 
9 KPC-2 and KPC-3 carbapenemases 
in urinary E. coli isolates from 7 long-
term care facilities. We report such an 
isolate from a resident of a long-term 
care facility.
This case involved a 68-year-old 
female  resident  of  a  long-term  care 
facility in Centralia, Illinois, who had 
multiple  chronic  medical  problems, 
including  cerebral  palsy,  a  seizure 
disorder,  and  recurrent  urinary  tract 
infections. A urine culture grew >105 
CFU/mL of E. coli susceptible to ami-
kacin,  gentamicin,  tobramycin,  pip-
eracillin/tazobactam,  trimethoprim/
sulfamethoxazole, imipenem, and ni-
trofurantoin.  Tigecycline  susceptibil-
ity was not determined. Trimethoprim/
sulfamethoxazole  therapy  was  initi-
ated. Follow-up urine culture almost 
3 weeks later again grew >105 CFU/
mL of E. coli, now susceptible to ami-
kacin, gentamicin, tobramycin, nitro-
furantoin, and tigecycline. The isolate 
was resistant to imipenem and mero-
penem. A modified Hodge test demon-
strated production of a carbapenemase 
(7), and the blaKPC gene was detected 
by  PCR  at  the  Centers  for  Disease 
Control  and  Prevention  (CDC).  The 
patient  was  treated  with  a  10-day 
course  of  nitrofurantoin,  100  mg  by 
gastrostomy  tube  2×  per  day.  Chart 
review indicated that contact precau-
tions were instituted only after discov-
ery of the second E. coli isolate.
Seventeen  days  later,  a  repeat 
urine culture grew >105 CFU/mL of K. 
pneumoniae susceptible only to ami-
kacin,  gentamicin,  tobramycin,  and 
tigecycline. No treatment was given. 
Follow-up  urine  culture  grew  >105 
CFU/mL of K. pneumoniae again with 
a similar resistance pattern. The modi-
fied Hodge test result was positive (7) 
and was confirmed as blaKPC positive 
by  PCR  at  CDC.  The  resident  was 
transferred to an acute care facility for 
further evaluation and was treated with 
amikacin. At completion of therapy, a 
repeat urine culture was negative for 
organisms.
Our case, like that of Urban et al. 
(6), involved a urinary isolate from a 
resident of a long-term care facility. 
As  increasing  numbers  of  resistant 
gram-negative  rods  colonize  such 
patients,  the  patients  may  acquire  a 
bacterium  carrying  a  KPC  plasmid 
conferring broad-spectrum resistance 
as described in our patient. These plas-
mids may then be laterally transferred 
to  other  gram-negatives,  which  may 
have occurred in this case.
Our case underscores the gravity 
of the evolutionary process of emer-
gent,  multidrug–resistant  enterobac-
teriaceae. Even though E. coli strains 
that harbor carbapenemase genes are 
not ubiquitous, additional therapeutic 
interventions  are  needed  to  prevent 
the spread of these bacteria, which are 
likely to infect increasing numbers of 
patients.
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Bedbugs and 
Healthcare- 
associated  
Dermatitis, France
To the Editor: Bedbugs (Cimex 
lectularius)  are  hematophagous  in-
sects. Adults are 4–6 mm long, flat-
tened, oval and wingless, and brown 
to brownish–red (Figure, panel A) (1). 
They may feed in the wild on birds or 
bats (2), but they are mainly associ-
ated  with  human  dwellings  and  can 
be found on furniture and clothing (3). 
Because  bedbugs  are  nocturnal  and 
feed painlessly only in the dark, while 
humans  sleep,  initial  bedbug  prolif-
eration  usually  goes  unnoticed  until 
several weeks later when the patient 
discovers  a  pruritic  cutaneous  erup-
tion of unknown origin (4). Decades 
ago,  bedbugs  were  frequently  found 
worldwide,  but  reports  of  cases  in 
industrialized countries have progres-
sively declined, probably the result of 
improved living conditions (3). They 
nonetheless  remain  a  pest  in  less-
developed  countries  and  in  the  wild 
(5). The past 10 years have seen the 
revival of this insect in industrialized 
countries  (3,6,7).  Increasing  reports 
describe  isolated  cases  or  bedbugs 
spreading throughout a single building 
(8). We report an outbreak of health-
care-associated  dermatitis  caused  by 
bedbugs in a hospital nursing home in 
Cannes, French Riviera.
In July 2007, Mrs. Q arrived, with 
her  bed  and  mattress,  for  admission 
to a single room in a hospital nursing 
home. This facility has 112 rooms lo-
cated on 2 floors, each having A and 
B  wings.  Mrs.  Q’s  first  lesions,  di-
agnosed  as  insect  bites,  appeared  in 
October  2007.  Concomitantly,  Mrs. 
T,  a  long-term  resident  of  the  room 
across the hall (1.5 m away), devel-
oped similar lesions. Examination of 
Mrs. Q’s room led to the discovery of 
an aggregation of 200 C. lectularius 
bedbugs beneath her mattress. In Mrs. 
T’s room, 15 bedbugs were identified 
(Figure 1, panel B). Suspected insect 
excreta  were  also  found  in  another 
nearby room. A private company con-
ducted a nonspecific pest-control in-
tervention in these 3 rooms.
In  November  2007,  another  2 
residents in rooms located 3 and 6 m 
away from Mrs. Q’s had insect-bite 
dermatitis: 15 bedbugs were found in 
each room. Over a 3-week period, the 
nursing home staff performed the sec-
ond pest-control intervention in these 
2 infested rooms and also treated 10 
adjacent  rooms.  They  disassembled 
furniture  and  applied  insecticides 
to  furniture,  room  corners  (imipro-
thrine and cypermethrine), and cloth-
ing  (esdepallethrine  and  piperonyl   
butoxide).
No  additional  skin  lesions  oc-
curred during the next 4 months, and 
no  new  resident  was  admitted.  In 
March 2008, a new long-term resident 
developed  similar  bedbug-dermatitis 
lesions (Figure, panel C); 12 C. lectu-
larius bedbugs were found in his room 
(33 m from Mrs. Q’s room, same floor, 
wing B). This time, a specialized pri-
vate  company  conducted  the  pest-
control  intervention  over  a  2-month 
period in the 56 rooms on the second 
floor (wings A and B); they treated fur-
niture and clothing and placed silicone 
sealer  around  doors  and  floorboards 
to obstruct potential pest refuges. All 
furniture was removed, disassembled, 
and washed. When no bedbugs or eggs 
were  found,  bendiocarb  was  applied 
preventively;  otherwise,  curative  d-
trans-tetramethrin was applied (3). No 
further infestation has been observed.
Three  pest-control  interventions 
were  required  to  eliminate  these  in-
festations. The first was not specific 
for bedbugs, and the second was not 
sufficiently  extensive.  Only  specific 
and extensive insecticide application 
achieved elimination. The temporal–
spatial distribution of dermatitis in this 
facility suggests 2 types of transmis-
sion: during the first 2 waves, spon-
taneous movement of the bedbugs is 
the  most  likely  hypothesis  because 
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